About OzemNews
Who we are
OzemNews is an independent publication dedicated to news and updates about Ozempic and GLP-1 treatments. Our goal is to provide up-to-date, evidence-based information for patients and healthcare professionals.
Our mission
To follow and translate the latest developments in GLP-1 treatments into accessible, accurate and up-to-date content.
Editorial commitment
All news is reviewed by our editorial team and based on scientific and official sources (PubMed, regulatory agencies, FDA, EMA). This content is informational and does not replace medical advice.
Contact
For questions, suggestions or partnerships, reach out by email: contato@ozempro.com